Acer Therapeutics Inc
ACER
ACER was delisted on the 8th of November, 2023.
28 hedge funds and large institutions have $1.96M invested in Acer Therapeutics Inc in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 0 closing their positions.
2,575% more call options, than puts
Call options by funds: $107K | Put options by funds: $4K
80% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 5
33% more funds holding
Funds holding: 21 → 28 (+7)
52% less capital invested
Capital invested by funds: $4.12M → $1.96M (-$2.16M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$99.9K |
| 2 |
CF
Copperwynd Financial
Scottsdale,
Arizona
|
+$48.7K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$47.3K |
| 4 |
HAIM
Hunter Associates Investment Management
Pittsburgh,
Pennsylvania
|
+$39.8K |
| 5 |
BlackRock
New York
|
+$35.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$77.1K |
| 2 |
State Street
Boston,
Massachusetts
|
-$4.4K |
| 3 |
Goldman Sachs
New York
|
-$3.88K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$438 |
| 5 |
Bank of New York Mellon
New York
|
-$121 |
ACER Hedge Fund Activity: Q2 2022 in Review
28 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q2 2022, worth a combined $1.96M — down 52% from $4.12M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new ACER positions and 0 closed out — a net gain of 7 holders — while 9 added to existing stakes and 5 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $99.9K. The largest seller was Nantahala Capital Management, cutting an estimated $77.1K.
- 28 institutional investors held Acer Therapeutics Inc (ACER) as of Q2 2022, up from 21 in Q1 2022.
- Funds reported $1.96M of Acer Therapeutics Inc stock for Q2 2022, down 52% quarter-over-quarter.
- 7 funds opened new Acer Therapeutics Inc positions in Q2 2022 and 0 closed out, a net change of +7 holders.
- The largest Acer Therapeutics Inc buyer in Q2 2022 was Renaissance Technologies, an estimated $99.9K added.
- The largest Acer Therapeutics Inc seller in Q2 2022 was Nantahala Capital Management, an estimated $77.1K sold.
Based on aggregated 13F filings for Q2 2022.